ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 86 filers reported holding ADURO BIOTECH INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $15,765,000 | -80.4% | 5,971,410 | -45.3% | 0.00% | -76.5% |
| Q3 2018 | $80,249,000 | +4.5% | 10,917,990 | -0.5% | 0.02% | 0.0% |
| Q2 2018 | $76,830,000 | -26.4% | 10,975,618 | -2.3% | 0.02% | -29.2% |
| Q1 2018 | $104,451,000 | +32.0% | 11,231,259 | +6.4% | 0.02% | +41.2% |
| Q4 2017 | $79,144,000 | -25.8% | 10,552,763 | +5.4% | 0.02% | -29.2% |
| Q3 2017 | $106,671,000 | -3.3% | 10,015,982 | +3.5% | 0.02% | -7.7% |
| Q2 2017 | $110,295,000 | +8.6% | 9,675,019 | +2.4% | 0.03% | +8.3% |
| Q1 2017 | $101,571,000 | +2.9% | 9,448,529 | +9.1% | 0.02% | -4.0% |
| Q4 2016 | $98,687,000 | +26.1% | 8,656,759 | +37.4% | 0.02% | +25.0% |
| Q3 2016 | $78,290,000 | +347.9% | 6,298,477 | +307.5% | 0.02% | +300.0% |
| Q2 2016 | $17,481,000 | – | 1,545,585 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |